Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CoreWeave, Inc. (Nasdaq: CRWV) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. As a publicly traded Software - Infrastructure company focused on AI cloud services, CoreWeave uses its filings to describe material agreements, financing arrangements, and significant corporate events.
In its Form 8-K filings, CoreWeave has reported material definitive agreements such as master services agreements and order forms with OpenAI, Meta Platforms, Inc., and NVIDIA Corporation, which govern access to cloud computing capacity and reserved capacity arrangements. The company has also disclosed credit agreements and delayed draw term loan facilities used to finance capital expenditures for GPU servers, infrastructure, and systems that support strategic customer contracts.
CoreWeave’s filings include detailed descriptions of its debt and capital structure, such as senior notes, revolving credit facilities, and convertible senior notes due 2031. These documents outline terms like interest rates, maturity dates, conversion features, capped call transactions, guarantees by subsidiaries, and financial covenants. Investors can review these filings to understand how CoreWeave funds its AI infrastructure and manages potential dilution.
Other 8-K filings cover topics such as the termination of a proposed merger agreement, changes in classification of equity related to preferred stock put rights, and the registration of Class A common stock on The Nasdaq Stock Market LLC under the symbol CRWV. Results of operations and financial condition for specific quarters are also furnished via 8-K exhibits.
On Stock Titan, AI-powered tools can help summarize lengthy CoreWeave filings, highlight key terms in documents like credit agreements and indentures, and surface information on topics such as material customer contracts, new financing facilities, and significant corporate events. Users can quickly locate references to items like convertible notes, capped call transactions, or major AI infrastructure commitments without reading every page.
CoreWeave, Inc.’s Chief Development Officer, McBee Brannin, reported trust-level share conversions and sales on February 9, 2026. Trusts associated with Brannin converted Class B Common Stock into Class A Common Stock, then sold small blocks of Class A shares in multiple transactions.
The Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 Family Trust LLC, and Canis Minor 2025 Family Trust LLC executed the trades. Sales of Class A shares occurred at prices ranging from about $89.76 to $97.35 per share under a Rule 10b5-1 trading plan adopted on November 17, 2025.
CoreWeave, Inc.’s Chief Development Officer Brannin McBee reported converting 102,830 shares of Class B Common Stock into Class A directly, and 25,000 Class B shares held by the Brannin J. McBee 2022 Irrevocable Trust into Class A.
Following these conversions, McBee and two family trusts reported multiple open‑market sales of Class A shares under a Rule 10b5‑1 trading plan adopted on November 17, 2025, at weighted average prices within ranges from $89.09 to $97.85 per share. After these transactions, McBee beneficially owned 248,664 Class A shares directly, 54,500 Class A shares through the Canis Major Trust, and 8,294,490 Class B shares directly, plus 3,991,020 Class B shares through the 2022 Irrevocable Trust.
CRWV insider has filed a Rule 144 notice to sell up to 50,000 common shares through Morgan Stanley Smith Barney LLC on or about 02/11/2026 on NASDAQ, with an aggregate market value of $4,755,500.
The shares are founder shares acquired from the issuer on 11/13/2017. The filing also lists multiple recent Rule 10b5-1 common stock sales by Michael Intrator, Omnadora Capital LLC, and a non‑affiliate donee over the prior three months, with individual transactions ranging from 32,455 to 78,971 shares.
CRWV insider activity shows a planned Rule 144 sale of 32,455 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $3,086,795.05, on or about February 11, 2026 on NASDAQ.
The seller acquired these 32,455 shares as founder shares on November 13, 2017. Recent activity also includes multiple 10b5-1 plan sales by Michael Intrator and Omnadora Capital LLC over the prior three months, each involving blocks of common stock with multi‑million dollar gross proceeds.
A Form 144 filing for CRWV reports a planned sale of 500 shares of common stock with an aggregate market value of 44975.00. The shares, described as Founders Shares, were acquired from the issuer on 02/25/2019 and will be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with 386401201 shares of common stock outstanding.
The notice also lists extensive recent Rule 10b5-1 sales of CRWV common stock from 12/01/2025 through 02/02/2026 by Brannin McBee, related trusts and LLCs, and a non-affiliate donee, covering multiple block transactions and multi-million-dollar gross proceeds.
CRWV filed a notice that a shareholder plans to sell 102,830 common shares, with an aggregate market value of 9249558.50, through Morgan Stanley Smith Barney on 02/09/2026 on NASDAQ. The filing notes 386,401,201 common shares outstanding. The shares were originally acquired as founder shares on 02/25/2019.
The notice also lists extensive recent Rule 10b5-1 sales of CRWV common stock over the past three months by Brannin McBee, related trusts and entities, and a non-affiliate donee, including individual trades such as 102,835 shares for 9799589.34 and 257,733 shares for 19592527.61.
CRWV received a Rule 144 notice for the planned sale of 3,000 common shares, with an aggregate market value of $269,850. These are founder shares acquired on February 25, 2019, to be sold through Morgan Stanley Smith Barney on the NASDAQ around February 9, 2026.
The filing notes that 386,401,201 common shares are outstanding. It also lists numerous recent 10b5-1 sales of CRWV common stock in late 2025 and early 2026 by Brannin McBee and various Canis Major/Canis Minor trusts, with individual transactions ranging from 500 shares to over 102,835 shares and gross proceeds in the millions of dollars.
CRWV has a Rule 144 notice covering the planned sale of 1,000 common shares, with an aggregate market value of $89,950, through Morgan Stanley Smith Barney on the NASDAQ around February 9, 2026. The filing lists 386,401,201 common shares outstanding for context.
The seller acquired these 1,000 shares as founders’ shares on February 25, 2019. The notice also details extensive prior Rule 10b5-1 sales over the past three months by Brannin McBee, related trusts, and other entities, including individual transactions such as 102,835 shares sold for more than $8.1 million and 257,733 shares sold for about $19.6 million.
A shareholder filed a notice of proposed sale of 1,000 shares of common stock, with an aggregate market value of $89,950.00. The shares are to be sold on NASDAQ around 02/09/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were originally acquired as founders shares from the issuer on 02/25/2019. The filing also lists extensive Rule 10b5-1-labeled sales of common stock over the past three months by Brannin McBee, related trusts and entities, and a non-affiliate donee, each with specified dates, share amounts, and gross proceeds.
CRWV filed a notice under Rule 144 for a planned sale of restricted or control securities. The filing shows a holder intends to sell 25,000 common shares through Morgan Stanley Smith Barney Executive Financial Services, with an aggregate market value of $2,248,750, against 386,401,201 shares outstanding. The approximate sale date is February 9, 2026 on NASDAQ. The shares were acquired as founders shares from the issuer on February 25, 2019. The notice also lists extensive Rule 10b5-1 sales of common stock during the prior three months by Brannin McBee, several related trusts and LLCs, and a non-affiliate donee, each with specific dates, share amounts, and gross proceeds.